Navigation Links
GeneLink Biosciences Completes Sale of GeneWize Life Sciences
Date:2/16/2012

ORLANDO, Fla., Feb. 16, 2012 /PRNewswire/ -- GeneLink Biosciences, Inc. (OTCBB: GNLK), a leading consumer genomics biotech company, has completed the sale of the stock of its wholly owned direct-selling subsidiary GeneWize Life Sciences, Inc. (GeneWize)  to Capsalus Corp. (OTCBB: WELL), another public company operating in the health and wellness marketplace.  As previously disclosed, GeneLink and Capsalus executed definitive agreements for the sale of GeneWize on October 13, 2011 and GeneLink obtained shareholder approval of the transaction at a Special Shareholders Meeting on January 25, 2012.

GeneLink is a leader in consumer genomics, combining genetic science, wellness and customization to create innovative consumer products, including skincare and nutritional supplements personalized to reflect important elements of the individual customer's genetic profile. Through its operation of GeneWize, GeneLink has generated more than $25 million in revenues over the past three years, demonstrating the commercial viability of these DNA-customized products.

"The sale of GeneWize is an important step in GeneLink's strategy of leveraging the strengths of its sales and marketing partners in order to focus on the company's core competencies, and thus accelerate its growth," said Bernard L. Kasten Jr., M.D., GeneLink's Chairman and CEO.   "We are already impressed with the commitment and resources which Capsalus and its partners are bringing to GeneWize.  We would like nothing more than to see GeneWize and its brand partners flourish while supporting and selling GeneLink's genetic assessments and genetically influenced consumer products."

GeneLink Biosciences, Inc. (www.genelinkbio.com) is a 17-year old leading biosciences company specializing in consumer genomics. GeneLink's patented technologies include proprietary DNA assessments linked to personalized health,
'/>"/>

SOURCE GeneLink Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. GeneLink Marketing Efforts Poised to Show Results
2. GeneLink BioSciences, Inc. Ranked Number 33 Fastest Growing Company in North America on Deloittes 2011 Technology Fast 500™
3. GeneLink Reports Second Quarter 2011 Results
4. GeneLink Biosciences Expands its Scientific Advisory Board to Support New Product Lines
5. GeneLink Reports Denial of Appeal
6. GeneLink Reports 2010 Results
7. GeneLink Announces New Licensing Partner
8. GeneLink Reports Third Quarter Results
9. GeneLink BioSciences, Inc. Ranked 62nd Fastest Growing Company in North America on Deloittes 2010 Technology Fast 500™
10. GeneLink Announces HelixLife Private Label Distribution Agreement
11. GeneLink Reports First Quarter Gains
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... HAMILTON, Bermuda , July 1, 2015 /PRNewswire/ ... biopharmaceutical company focused on the treatment of dementia, ... investor briefing on July 22 at 5:45 p.m. ... at the Alzheimer,s Association International Conference 2015 (AAIC). ... following remarks: , Dr. Lawrence ...
(Date:7/1/2015)... ... 2015 , ... A newly launched business plan contest will ask startup companies ... in life sciences R&D. The Pistoia Alliance President’s Startup Challenge 2015 will see small ... period of expert mentorship from a senior industry figure drawn from the Pistoia Alliance ...
(Date:7/1/2015)... Indianapolis, IN (PRWEB) , ... July 01, 2015 , ... ... the 2015 BIO International Convention in Philadelphia, PA. , The presentation took ... milestones and outlined the plans for the development of APX3330 for the treatment of ...
(Date:7/1/2015)...  UCB, a multinational biopharmaceutical company, and Genpact ... designing, transforming, and running intelligent business operations, have ... their close collaboration in driving transformation that achieved ... (GBS) finance organization. The Aecus Innovation ... together effectively to embrace the innovative promise of ...
Breaking Biology Technology:Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 2Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 3Pistoia Alliance Launches Startup Challenge 2Pistoia Alliance Launches Startup Challenge 3Apex Therapeutics Presented Company Overview at This Year’s BIO International Convention in Philadelphia, PA 2UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 2UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 3UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 4UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 5
... Calif., May 30 AMDL, Inc. (Amex:,ADL), ... with,operations in Shenzhen, Jiangxi and Jilin, China, announced ... anti-aging line., The company is releasing the ... of AMDL,s Chinese subsidiary Jade Pharmaceutical,Inc. (JPI). Scheduled ...
... Dx(TM) Genomic Grade Could Spare Tens ... ASCO Annual Meeting, ... Ipsogen SA (Marseilles, France and New,Haven, CT, USA), a ... that it is entering the breast cancer,diagnostic market with the ...
... Phase I/II Study of Zalutumumab in, Combination With Irinotecan Chemotherapy ... ... COPENHAGEN, Denmark, May 30 Genmab A/S (OMX:,GEN) announced today ... with irinotecan chemotherapy to treat,colorectal cancer (CRC). The study will include ...
Cached Biology Technology:AMDL Announces New GOODNAK Consumer Anti-Aging Products for Use in Skin Renewal Treatments 2Ipsogen Launches MapQuant Dx(TM) Genomic Grade Test to Identify Breast Cancer Patients who Benefit From Chemotherapy 2Ipsogen Launches MapQuant Dx(TM) Genomic Grade Test to Identify Breast Cancer Patients who Benefit From Chemotherapy 3Ipsogen Launches MapQuant Dx(TM) Genomic Grade Test to Identify Breast Cancer Patients who Benefit From Chemotherapy 4Genmab Initiates Zalutumumab Combination Study in Colorectal Cancer 2Genmab Initiates Zalutumumab Combination Study in Colorectal Cancer 3
(Date:6/29/2015)... Research and Markets( http://www.researchandmarkets.com/research/zj7h4f/latin_america ... America Biomedical Sensors Market - Growth, Trends & Forecasts ... Latin America Biomedical Sensors market is estimated at $0.65 ... the period 2014-2020 The near future will ... formulation of each individual. These sensors can be set ...
(Date:6/25/2015)... 25, 2015 According to ... (Swipe & Area), Technology, Material (Optical Prism, Piezoelectric, ... Security & Others) & Geography - Global Forecast ... said market is expected to reach $14,500.07 Million ... Browse 76 market Tables and 109 ...
(Date:6/25/2015)... 2015  TAKE Solutions Ltd., a global business technology ... States Patent and Trademark Office (USPTO) for its "Method ... Solutions, Clinical Accelerators to reduce the time taken to ... standardization without the accelerators), thus reducing time to market. ... At the heart of the patented Clinical Data Standardization ...
Breaking Biology News(10 mins):Latin America Biomedical Sensors Market Report 2015-2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 4TAKE Solutions Awarded Patent By USPTO 2
... AMHERST, Mass. When researchers at the University of ... the bacterium Geobacter sulfurreducens conducts ... physicists quite comfortable with the idea of such a ... "For biologists, Geobacter ,s behavior represents a ...
... (DFG, German Research Foundation) is establishing eight new Research ... its 2013 March meeting in Bonn. The research collaborations ... pressing issues in their research areas and to establish ... Units, the new units will be interdisciplinary and span ...
... in modern warfare, often resulting in severe tissue damage, ... to the new research presented today at the 2013 ... (AAOS). The Return to Run (RTR) program is ... high-level function to wounded warriors. It includes use ...
Cached Biology News:UMass Amherst researchers reveal mechanism of novel biological electron transfer 2UMass Amherst researchers reveal mechanism of novel biological electron transfer 3DFG establishes 8 new research units 2DFG establishes 8 new research units 3DFG establishes 8 new research units 4DFG establishes 8 new research units 5
... XIII in both reduced and non-reduced forms. It ... or human Factor XII. Factor XIII is a ... two subunits. Factor XIII-A is the catalytic subunit ... XIII is present in plasma as an Alpha2Beta2 ...
... Anti-Lipid Phosphate Phosphatase 2 ... buffered aqueous solution ... saline containing 0.08% sodium ... from the human LPP2 ...
Anti-CaM kinase II recognizes the enzymes a subunit (6) and reacts with tissue from all mammalian species tested, as well as with chicken and frog tissues....
... Anti-MAPKAPK-2, Phospho-Specific(Thr 222 ) ... NaCl, 10 mM sodium HEPES, ... pH 7.5. Recognizes the ~47 ... 2 (MAPKAPK-2) protein phosphorylated at ...
Biology Products: